KRSA
Korsana Biosciences, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$34.99
+3.77%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 660.13x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 428.95x
- Price / sales
- 1148.46x
- Price / cash flow
- -490.24x
Enterprise value
- Enterprise value
- $2.2B
- EV / sales
- 1147.73x
- EV / EBITDA
- -325.14x
- EV / EBIT
- -319.56x
- Market cap
- $2.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026